ASCO: Debulking Predicts Survival in Recurrent Ovarian Cancer

posted on Jun 07 by MedPage Today OB/Gyn in the Uncategorized category CHICAGO (MedPage Today) -- The success of primary surgery for ovarian cancer predicted progression-free and overall survival in recurrent disease among patients with at least a 12-month platinum-free interval, data from three large clinical trials showed.